Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation

被引:18
|
作者
Boriani, G
Biffi, M
Capucci, A
Botto, GL
Broffoni, T
Rubino, I
Della Casa, S
Sanguinetti, M
Branzi, A
Magnani, B
机构
[1] Univ Bologna, Inst Cardiol, I-40138 Bologna, Italy
[2] Osped Civile, Dept Cardiol, Lugo, Spain
[3] Osped S Anna, Dept Cardiol, Como, Italy
来源
关键词
antiarrhythmic drugs; atrial fibrillation; conversion; Holter monitoring;
D O I
10.1111/j.1540-8159.1998.tb01202.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficacy and safety of propafenone as an oral loading dose (600-mg single oral dose) in converting recent-onset atrial fibrillation (less than or equal to 7 days duration) to sinus rhythm were evaluated in a single-blind, placebo-controlled study according to patients' age. Overall, 240 hospitalized patients, NYHA Class less than or equal to 2 without signs or symptoms of heart failure were enrolled: among patients aged less than or equal to 60 years, 55 were allocated to propafenone treatment and 59 to placebo, respectively, and among patients aged > 60 years, 64 were allocated to propafenone treatment and 62 to placebo, respectively. Results: In each age group, the likelihood of conversion to sinus rhythm was significantly greater after propafenone compared with placebo at 3 and 8 hours. For patients aged less than or equal to 60 years, corresponding odd ratios were 3.78 (95% CI = 1.80-7.92, P = 0.04) at 3 hours and 4.74 (95% CI = 2.22-10.54, P = 0.02) at 8 hours; for patients aged > 60 years odd ratios were 5.03 (95% CI = 2.08-12.12, P = 0.02) at 3 hours and 6.75 (95% CI = 3.28-73.86, P = 0.01) at 8 hours, respectively. Logistic regression analysis showed that conversion to sinus rhythm within 3 hours was predicted by age less than or equal to 60 years IP = 0.0064) and by propafenone treatment IP ( 0.0001), and conversion to sinus rhythm within 8 hours was predicted by age less than or equal to 60 years(P = 0.0467) and by propafenone treatment (P ( 0.0001). The occurrence of adverse effects was observed in 14%-16% of propafenone treated patients and in 8% of placebo treated patients without significant differences according to age. In conclusion, in patients with recent-onset atrial fibrillation without signs of heart failure, propafenone as a single oral loading dose is effective. It is also effective in selected elderly subjects with a favorable safety profile. Moreover, spontaneous conversion to sin us rhythm appears to occur less frequently in elderly patients.
引用
收藏
页码:2465 / 2469
页数:5
相关论文
共 50 条
  • [21] Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation - Results of a randomized, double-blind, controlled study
    Azpitarte, J
    Alvarez, M
    Baun, O
    Garcia, R
    Moreno, E
    Martin, F
    Tercedor, L
    Fernandez, R
    EUROPEAN HEART JOURNAL, 1997, 18 (10) : 1649 - 1654
  • [22] Comparison of oral loading dose of propafenone versus amiodarone in converting recent onset atrial fibrillation to sinus rhythm
    Blanc, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 383A - 383A
  • [23] Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias
    Rae, AP
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8A): : 59N - 65N
  • [24] Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease - A randomized, controlled trial
    Boriani, G
    Biffi, M
    Capucci, A
    Botto, GL
    Broffoni, T
    Rubino, I
    DellaCasa, S
    Sanguinetti, M
    Magnani, B
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) : 621 - 625
  • [25] Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: Is in-hospital admission absolutely necessary?
    Botto, GL
    Bonini, W
    Broffoni, T
    Molteni, S
    Lombardi, R
    Alfieri, G
    Barone, P
    Bernasconi, G
    Ferrari, G
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (11): : 1939 - 1943
  • [26] CLINICAL COURSE OF RECENT-ONSET ATRIAL-FIBRILLATION TREATED WITH ORAL PROPAFENONE
    WEINER, P
    GANAM, R
    GANEM, R
    ZIDAN, F
    RABNER, M
    CHEST, 1994, 105 (04) : 1013 - 1016
  • [27] CONVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION TO SINUS RHYTHM USING A SINGLE ORAL LOADING DOSE OF PROPAFENONE - A SINGLE-BLIND CONTROLLED-STUDY
    BOTTO, GL
    FALCONE, C
    BONINI, W
    BROFFONI, T
    ESPUREO, M
    JEMOLI, R
    MOLTENI, S
    FERRARI, G
    CIRCULATION, 1993, 88 (04) : 66 - 66
  • [28] Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
    Taha, Hesham S.
    Youssef, Ghada
    Omar, Ramy M.
    El Din, Ahmed M. Kamal
    Din, Ahmed A. Shams
    Meshaal, Marwa S.
    INDIAN HEART JOURNAL, 2022, 74 (03) : 212 - 217
  • [29] Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias: Discussion
    Camm, J
    Rae, AP
    Winters, S
    Page, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8A): : 65N - 65N
  • [30] Comparison between oral propafenone and amiodarone to restore sinus rhythm in patients with recent-onset atrial fibrillation
    Blanc, JJ
    Thibout, E
    Boer, F
    CIRCULATION, 2004, 110 (17) : 461 - 461